Type 2 & other diabetes

The Separate and Combined Effects of GIP, GLP-1, and GLP-2 on Markers of Bone Turnover in Type 2 Diabetes

J Clin Endocrinol MetabPublished Randomised crossover study

Authors' conclusion

Our findings suggest that postprandial suppression of bone resorption in individuals with T2D is mediated by the additive effects of GIP, GLP-1, and GLP-2.

Study context

Population
Individuals with T2Dcrossover
Participants
10 individuals
Comparison
Oral glucose tolerance test (OGTT) vs isoglycaemic IV glucose infusions (IIGI) with saline, GIP, GLP-1, GLP-2, and GIP + GLP-1 + GLP-2 infusions
Primary endpoint
Changes in plasma β-CTX-I and PINP
Methodological detailsrandomized, 6 experimental days
  • Randomized
  • 6 experimental days

Primary result

As reported in the abstract

  • β-CTX-I significantly suppressed during OGTT vs IIGI
  • IIGI with GIP + GLP-1 + GLP-2 suppressed β-CTX-I comparably to OGTT
  • No reduction in PINP during IIGI with GIP, GLP-1, and GIP + GLP-1 + GLP-2
  • PINP significantly reduced during OGTT and during IIGIs with saline and with GLP-2

Original publication

The Separate and Combined Effects of GIP, GLP-1, and GLP-2 on Markers of Bone Turnover in Type 2 Diabetes. J Clin Endocrinol Metab. Published 29 August 2025. doi:10.1210/clinem/dgaf482

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.